5 Value Stocks Trading at Attractive Price-to-Sales Ratios
Low price-to-sales stocks like SCVL, NUS, APLE, COP and FAF screen as undervalued, with the setup hinging on debt levels, strong cash flow and business momentum.
NUS - Nu Skin Enterprises, Inc.
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$11.00
DETAILS
HIGH:
$11.00
LOW:
$11.00
MEDIAN:
$11.00
CONSENSUS:
$11.00
UPSIDE:
85.50%
Stock News
3 Cosmetics Stocks Gaining From AI, Wellness and Innovation Trends
EL, NUS and COTY tap AI, wellness and innovation trends as beauty demand evolves across skincare, cosmetics and fragrance categories.
Nu Skin Reaches 900 Million Meals Purchased and Donated in its Global Fight for Child Nutrition
PROVO, Utah--(BUSINESS WIRE)--Nu Skin Enterprises, Inc. (NYSE: NUS), a global leader in beauty and wellness, today announced it has reached the milestone of providing 900 million meals for children since 2002 through its Nourish the Children initiative. Malnourished children in more than 65 countries around the world have been fed VitaMeal,* a nutrient-dense food, from one of the company's third-party charity partners after Nu Skin sales leaders, customers or employees purchase and donate bags.
Nu Skin Enterprises Q1 Earnings Call Highlights
Nu Skin Enterprises NYSE: NUS reported first-quarter 2026 results that management said were in line with expectations, as the company continued to invest in its Prysm iO wellness platform and emerging-market expansion while navigating macroeconomic pressures on consumers and supply chains.
Stonegate Capital Partners Updates Coverage on NU Skin Enterprises Inc. (NUS) 1Q26
Dallas, Texas--(Newsfile Corp. - May 8, 2026) - NU Skin Enterprises Inc. (NYSE: NUS): Stonegate Capital Partners updates their coverage on NU Skin Enterprises Inc. (NYSE: NUS). NUS reported revenue, adj NI, and adj EPS of $320.6M, $6.8M, and $0.14, respectively.
Nu Skin Enterprises, Inc. (NUS) Q1 2026 Earnings Call Transcript
Nu Skin Enterprises, Inc. (NUS) Q1 2026 Earnings Call Transcript
Nu Skin Enterprises (NUS) Q1 Earnings and Revenues Lag Estimates
Nu Skin Enterprises (NUS) came out with quarterly earnings of $0.14 per share, missing the Zacks Consensus Estimate of $0.15 per share. This compares to earnings of $0.23 per share a year ago.
Nu Skin Enterprises Reports First Quarter Results
PROVO, Utah--(BUSINESS WIRE)---- $NUS--Nu Skin Enterprises Inc. (NYSE: NUS) today announced first quarter revenue results within its guidance range. Executive Summary Q1 2026 vs. Prior-year Quarter Revenue $320.6 million; (12.0)% • +1.1% FX impact or $3.9 million Earnings Per Share (EPS) $0.04 or $0.14 excluding certain charges compared to $2.14 or $0.23 excluding one-time gain from Mavely sale and other charges Customers 669,535; (14)% Paid Affiliates 120,850; (8)% Sales Leaders 26,915; (13)% “We del.
Nu Skin Enterprises Announces Quarterly Dividend
PROVO, Utah--(BUSINESS WIRE)---- $NUS--Nu Skin Enterprises, Inc. (NYSE: NUS) today announced its board of directors has declared a quarterly cash dividend of $0.06 per share, which will be paid on June 10, 2026, to shareholders of record on May 29, 2026. About Nu Skin Enterprises Inc. Nu Skin Enterprises Inc. (NYSE: NUS) is an intelligent beauty and wellness company, powered by a dynamic affiliate opportunity platform, which operates in nearly 50 markets worldwide. Backed by more than 40 years of scient.
Buy 14 Ideal Graham Value All-Stars Of 27 'Safer' Dividends In 71 April/May GVAS
The April/May 2026 Ben Graham All-Star Value Dogs list highlights 14 'safer,' fair-priced large-cap value stocks with robust, reliable dividends. Analyst forecasts project average net gains of 39.88% by April/May 2027 for the top ten yielding GASV stocks, with risk profiles generally below market average. Dividend safety is emphasized: 27 of 71 GASV names are 'safer' by free cash flow, but only 14 are both 'safer' and fairly priced for immediate purchase.
Nu Skin Enterprises to Announce First Quarter 2026 Financial Results
PROVO, Utah--(BUSINESS WIRE)--Nu Skin Enterprises, Inc. (NYSE: NUS) today announced it will release first quarter 2026 results after the market closes on Thursday, May 7. The Nu Skin management team will host a conference call with the investment community later that same day at 5 p.m. ET. During the call, management will discuss recent results and upcoming business initiatives. The webcast of the conference call, including the financial information presented, will be available on the investor.
Nu Skin Launches Prysm iO™: A Revolutionary AI-Powered Platform for Personalized Nutritional Wellness
PROVO, Utah--(BUSINESS WIRE)--Nu Skin Enterprises Inc. (NYSE: NUS), the world's #1 company for beauty and wellness device systems,* today announced the general consumer availability in the U.S. of Prysm iO™, a breakthrough intelligent nutritional wellness platform designed to deliver a better understanding of how daily nutrition and supplement routines support overall wellness. Prysm iO will launch for consumers in other Nu Skin markets in the coming months. Compact, portable and powered by adv.
71 April Graham Value All-Stars (GVAS): 14 To Buy
The April 2026 GASV list highlights 14 fair-priced, 'safer' mid-to-large-cap value stocks with strong dividend profiles and positive free-cash-flow-yields. Top ten GASV stocks are projected to deliver average net gains of 43.98% by April 2027, with yields ranging from 7.47% to 13.59%. All top-ten GASV stocks are ideally priced, with dividends from $1K invested exceeding their share prices, though some financials fund dividends with borrowed money.
CWA Asset Management Group LLC Takes Position in Nu Skin Enterprises, Inc. $NUS
CWA Asset Management Group LLC bought a new position in Nu Skin Enterprises, Inc. (NYSE: NUS) in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 78,272 shares of the company's stock, valued at approximately $753,000. CWA Asset Management Group LLC
Nu Skin Enterprises Appoints Chelsea Lantz as Interim Chief Financial Officer
PROVO, Utah--(BUSINESS WIRE)--Nu Skin Enterprises, Inc. (NYSE: NUS) today announced the appointment of Chelsea Lantz as interim Chief Financial Officer, effective immediately. The appointment of Lantz comes after James Thomas stepped down as CFO to pursue an outside opportunity. “On behalf of our board, management and the entire Nu Skin team, we thank James for his leadership and significant contributions over 16 years at Nu Skin and wish him and his family well in their future pursuits,” said.
14 Ideal 'Safer' Dividend Buys From 70 Mid-March Graham Value All-Stars (GVAS)
Top ten large cap value (GASV) stocks are forecasted to deliver an average 38.12% net gain by mid-March 2027, with yields up to 13.03%. Analyst targets suggest the five lowest-priced, highest-yield GASV stocks could outperform, offering an 18.5% higher gain than the top ten as a group. Fourteen of twenty-nine 'safer' lowest-priced GASV stocks are currently buyable, with seven meeting the ideal dividend-to-price criteria for fair value.
Nu Skin Appoints Chayce Clark as COO
PROVO, Utah--(BUSINESS WIRE)--Nu Skin Enterprises Inc. (NYSE:NUS) today announced the appointment of Chayce Clark as chief operating officer effective immediately. Clark will be responsible for leading the company's revenue performance and end-to-end operational execution across the business in addition to maintaining his role as the company's chief legal officer. “Chayce has been a valuable part of our executive team and an important voice in our efforts to become the world's leading intellige.
14 Ideal 'Safer' Dividend Buys From 29 Of 69 March Graham Value All-Stars (GVAS)
March's Large Cap Value (GASV) screen highlights 14 fair-priced, 'safer' dividend stocks, including Hafnia Ltd, IRSA Inversiones, and Weibo Corp, as actionable buys. Top ten GASV stocks are projected to deliver an average 33.21% net gain by March 2027, with risk/volatility slightly below the market average. Analyst targets indicate the five lowest-priced, highest-yield GASV stocks could outperform, with Hafnia Ltd showing a potential 42.88% gain.
Nu Skin: Patience Is Still Advised
Nu Skin Enterprises trades at a deep value multiple (~3x 2026 EBITDA) but faces persistent core business decline and unproven turnaround catalysts. Guidance disappointed, yet management expects margin expansion and a return to revenue growth by late 2026, with India and Prysm iO launches as key potential drivers. Non-core assets and a net cash-positive balance sheet provide some downside protection, but secular decline in legacy markets remains a major overhang.
Nu Skin Still Has Long-Term Turnaround Potential
Nu Skin is rated a buy, trading at low multiples with turnaround prospects tied to India expansion and Prysm iO device launch. NUS's core MLM business faces structural decline, but new product and market initiatives could stabilize or grow revenue beyond 2026. Prysm iO potential subscription fees may provide incremental revenue not fully reflected in current guidance.